NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Weiss Asset Management LPInsider2026-09-237,457,060$17.00
$126.77MSell
Rhonda FarnumSVP2026-09-153,329$17.03
$56.71kSell
Rhonda FarnumSVP2026-09-153,328$17.03
$56.69kSell
Rhonda FarnumSVP2026-09-156,657$17.03
$113.40kSell
Rhonda FarnumSVP2026-08-205,667$16.95
$96.06kSell
Rick E. WinninghamCEO2026-08-2020,034$16.95
$339.58kSell
Aziz SawafCFO;SVP2026-08-208,112$16.95
$137.50kSell
Aine MillerSVP;Head2026-08-206,258$16.95
$106.07kSell
Brett A. GrimaudSec;SVP2026-08-207,952$16.95
$134.79kSell
Eli Samaha10% Owner2026-07-075,564$17.17
$95.54kSell

1 of 5

TBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eli Samaha34.05%17,678,839$301.07MInsider
Glaxosmithkline PLC18.58%9,644,807$164.25MInsider
Weiss Asset Management LP14.36%7,457,060$126.99MInsider
Frank Pasqualone0.83%429,783$7.32MInsider
Andrew A. Hindman0.74%384,714$6.55MInsider
Kenneth R. Pitzer0.73%380,123$6.47MInsider
Philip D. Worboys0.64%330,752$5.63MInsider
Richard A. Graham0.61%314,915$5.36MInsider
Mathai Mammen0.55%288,111$4.91MInsider
Bradford J. Shafer0.54%277,831$4.73MInsider

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH0.09%76.12%Net SellingNet Selling
ALMS0.09%28.51%Net BuyingNet Buying
RIGL0.07%99.93%Net SellingNet Selling
ABUS0.05%99.95%Net BuyingNet Buying
SLBT0.00%60.21%Net BuyingNet Buying

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 0.09% institutional shareholders, 76.12% Theravance Biopharma insiders, and 23.78% retail investors. Eli Samaha is the largest individual Theravance Biopharma shareholder, owning 17.68M shares representing 34.05% of the company. Eli Samaha's Theravance Biopharma shares are currently valued at $301.07M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.